About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 40883 record(s)
Req # A-2016-001641
For the time period - January 1, 2015 to December 31, 2016 - all risk assessment reports/safety audit reports/test reports where the Department has identified a concern with any make-up or personal care products.Organization: Health Canada
June 2020
Req # A-2019-000936
Copy of the successful bidder's proposal for Request for Proposal (RFP)# 1000203303A - In vitro cell-based toxicity testing of vaping and heated tobacco devices.Organization: Health Canada
June 2020
Req # A-2019-001425
Health Canada clinical executive summaries for every submission pertaining to GARDASIL 9, which include: indications for use in men, Indigenous, First-Nation, Indian (registered with the Indian Registry) or Native American people/persons.Organization: Health Canada
June 2020
Req # A-2019-001553
Final version or latest draft and emails associated with Order Paper question Q-2522, put on notice on June 7, 2019. Time frame is June 7, 2019 to September 12, 2019.Organization: Health Canada
June 2020
Req # A-2019-000512
Adverse Reaction Report (AER) for fentanyl citrate injection. Report numbers: E2B_01772121, E2B_01683550, E2B_01769255, E2B_01786320, E2B_01786326.Organization: Health Canada
June 2020
Req # A-2019-000545
Adverse Reaction Report (AER). Report numbers: 000723351, 000725255, 000723313, 000723317, 000723597, 000723805, 000723923, 000725230, E2B_02447874, E2B_02449285, E2B_02452263, E2B_02454761.Organization: Health Canada
June 2020
Req # A-2019-001822
Adverse Reaction Report (AER). Report number: E2B_02747441.Organization: Health Canada
June 2020
Req # A-2019-001924
Adverse Reaction Report (AER) for Mesalazine. Report numbers: E2B_02776457, 000730742, 000730734.Organization: Health Canada
June 2020
Req # A-2019-002027
Adverse Reaction Report (AER). Report number: 000733211.Organization: Health Canada
June 2020
Req # A-2019-002081
Adverse Reaction Report (AER). Report numbers: E2B_02893727, E2B_02895533, E2B_02916646.Organization: Health Canada
June 2020